These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3851694)

  • 1. Comparison of patterns of hybrid resistance to the BALB/c plasmacytomas LPC-1 and MPC-11.
    Walker MC; Phillips-Quagliata JM
    Cancer Immunol Immunother; 1985; 20(1):47-54. PubMed ID: 3851694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid resistance to BALB/c plasmacytomas. I. Resistance to MPC-11 controlled by a locus not linked to H-2.
    Walker MC; Phillips-Quagliata JM
    J Immunol; 1979 Apr; 122(4):1535-43. PubMed ID: 448097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hybrid resistance to BALB/c plasmacytomas: F1 hybrid anti-MPC-11 immunological responses correlated with resistance to tumor challenge.
    Marsili MA; Walker MC; Phillips-Quagliata JM
    Cancer Res; 1986 Jan; 46(1):190-7. PubMed ID: 3484380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine susceptibility to mercury. II. autoantibody profiles and renal immune deposits in hybrid, backcross, and H-2d congenic mice.
    Hultman P; Bell LJ; Eneström S; Pollard KM
    Clin Immunol Immunopathol; 1993 Jul; 68(1):9-20. PubMed ID: 8513597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of F1 cytotoxic potentials by GvHR: role and mode of action of non-MHC genes that determine the hybrid resistance to GvHR-associated suppression of F1 cytotoxic potential.
    Ishikawa H; Kubota E; Saito K
    J Immunol; 1984 May; 132(5):2218-25. PubMed ID: 6232314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hybrid resistance to BALB/c plasmacytomas. II. Radiation sensitivity and silica insensitivity of resistance to MPC-11.
    Walker MC; Phillips-Quagliata JM
    J Immunol; 1979 Apr; 122(4):1544-7. PubMed ID: 221576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-2-linked genetic control of resistance to histocompatible tumors.
    Williams RM; Dorf ME; Benacerraf B
    Cancer Res; 1975 Jun; 35(6):1586-90. PubMed ID: 805662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic control of corticosteroid side-chain isomerase activity in the mouse.
    Walker MC; Marandici A; Martin K; Monder C
    Endocrinology; 1983 Mar; 112(3):924-30. PubMed ID: 6822218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new erythrocytic antigen of C57BL/10 (B10) mice.
    Walker MC; Phillips-Quagliata JM
    Proc Soc Exp Biol Med; 1985 Mar; 178(3):402-6. PubMed ID: 3975228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of susceptibility to Cryptococcus neoformans in mice.
    Rhodes JC; Wicker LS; Urba WJ
    Infect Immun; 1980 Aug; 29(2):494-9. PubMed ID: 7216421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Mls-1 locus and clonal deletion of T cells in susceptibility to collagen-induced arthritis in mice.
    Anderson GD; Banerjee S; Luthra HS; David CS
    J Immunol; 1991 Aug; 147(4):1189-93. PubMed ID: 1907992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis.
    Cheers C; McKenzie IF
    Infect Immun; 1978 Mar; 19(3):755-62. PubMed ID: 305895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of alien minor histocompatibility antigens distinct from tumor-specific transplantation antigen on a murine fibrosarcoma.
    Parmiani G; Colombo M; Ballinari D
    Int J Cancer; 1980 Oct; 26(4):461-5. PubMed ID: 7251224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interacting genetic factors controlling the antibody response against the H-2.2 specificity.
    Decoville M; Motta R
    Immunogenetics; 1982 Mar; 15(3):279-85. PubMed ID: 6802752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine cutaneous leishmaniasis: resistance in reconstituted nude mice and several F1 hybrids infected with Leishmania tropica major.
    Mitchell GF
    J Immunogenet; 1983 Oct; 10(5):395-412. PubMed ID: 6606002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of F1 cytotoxic potentials by graft-vs-host reaction. Cooperative non-H-2- and H-2D region-gene control of F1 natural resistance to graft-vs-host reaction-associated immunosuppression.
    Ishikawa H; Saito K; Kubota E
    J Immunol; 1989 Mar; 142(5):1495-9. PubMed ID: 2918225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological relationships during primary infection with Heligmosomoides polygyrus. Regulation of fast response phenotype by H-2 and non-H-2 genes.
    Wahid FN; Behnke JM
    Parasitology; 1993 Sep; 107 ( Pt 3)():343-50. PubMed ID: 8233595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of susceptibility to plasmacytoma induction. I. BALB/cAnN (C), C57BL/6N (B6), C57BL/Ka (BK), (C times B6)F1, (C times BK)F1, and C times B recombinant-inbred strains.
    Potter M; Pumphrey JG; Bailey DW
    J Natl Cancer Inst; 1975 Jun; 54(6):1413-7. PubMed ID: 1133851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific haplotype preference in congenic F1 hybrid mice in the cytotoxic T cell response to the male specific antigen H-Y.
    Müllbacher A; Sheena JH; Fierz W; Brenan M
    J Immunol; 1981 Aug; 127(2):686-9. PubMed ID: 6166683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yersinia enterocolitica infection in resistant and susceptible strains of mice.
    Hancock GE; Schaedler RW; MacDonald TT
    Infect Immun; 1986 Jul; 53(1):26-31. PubMed ID: 3721579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.